ArticlebioRxiv : the preprint server for biology2021

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern.

David W Hawman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.